Summary
Global Nursing Products Market was valued at USD 5.65 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.45% through 2029. The global nursing products market is a dynamic sector that encompasses a range of items used by nurses and healthcare professionals to enhance patient care and facilitate daily nursing tasks. This market includes products such as medical equipment, nursing apparel, personal protective equipment (PPE), nursing accessories, and software solutions for nursing management. The global nursing products market is poised for significant growth, driven by demographic changes, technological advancements, and a heightened focus on patient care. Stakeholders must navigate challenges and adapt to the evolving landscape to capitalize on emerging opportunities. By focusing on innovation, quality, and strategic partnerships, companies can position themselves effectively in this burgeoning market.
Key Market Drivers
Increasing Aging Population
The increasing aging population is a significant driver of growth in the global nursing products market, impacting various facets of healthcare delivery and shaping demand for specialized products. This demographic trend, characterized by a rising proportion of individuals aged 65 and older, has profound implications for nursing practices and the products required to support this aging demographic. As people age, their healthcare needs become more pronounced due to the natural decline in health associated with aging. Older adults often require more frequent check-ups and ongoing medical attention, leading to a higher demand for nursing staff and, by extension, the products they utilize. A significant percentage of the elderly population may require long-term care solutions, either in home care settings or in assisted living facilities. This necessitates a wide range of nursing products, from mobility aids to monitoring devices. The elderly are more susceptible to chronic diseases, including diabetes, heart disease, and arthritis. Products such as blood glucose monitors, blood pressure cuffs, and respiratory aids are essential for managing chronic conditions. The aging population increases the need for these specialized tools, directly impacting sales in the nursing products market. As chronic diseases often require a multi-disciplinary approach, there is a growing demand for nursing products that support integrated care, including telehealth solutions that facilitate remote monitoring and consultations. With the aging population, there is a heightened emphasis on maintaining a high quality of care. Healthcare providers are increasingly investing in nursing products that utilize advanced technologies, such as smart monitoring devices that track patient health metrics in real-time. The demand for these innovative products is amplified as healthcare facilities strive to improve patient outcomes for the elderly. There is a shift towards patient-centric care models that prioritize the individual needs of older adults. Nursing products that enhance the patient experience, such as ergonomic nursing tools and comfort-oriented apparel, are gaining traction.
The growing aging population is juxtaposed with a nursing workforce that is itself aging, leading to potential staffing shortages. To manage increased workloads with fewer staff, healthcare facilities are investing in nursing products that enhance efficiency, such as automated medication dispensing systems and electronic health record (EHR) solutions that streamline documentation processes. As the nursing workforce adapts to an older patient demographic, there is a need for educational products and training solutions that prepare nurses to effectively manage the unique challenges associated with caring for older adults. There is a concerted effort to enhance healthcare infrastructure, including the construction of specialized facilities (e.g., geriatric care centers) equipped with nursing products tailored for older patients. Many governments are implementing policies that promote better healthcare access for seniors, often resulting in increased funding for nursing products that meet regulatory and quality standards. Non-governmental organizations and advocacy groups are pushing for improved care for older adults, including access to necessary nursing products. This advocacy creates a favorable environment for manufacturers to develop and market products tailored to this demographic. Families are becoming more informed about the health needs of older relatives, driving demand for nursing products that facilitate home care, such as mobility aids, in-home monitoring systems, and safety equipment.
Rise in Chronic Diseases
The rise in chronic diseases is a significant factor driving the growth of the global nursing products market. Chronic diseases, which include conditions such as diabetes, cardiovascular diseases, obesity, and chronic respiratory diseases, are becoming increasingly prevalent worldwide. This trend presents both challenges and opportunities for healthcare providers and manufacturers of nursing products. Chronic diseases require ongoing management and care, resulting in a heightened demand for specialized nursing products tailored to these conditions. As patients with chronic diseases need regular monitoring, products such as glucometers, blood pressure monitors, and pulse oximeters are essential. The increasing prevalence of these diseases translates directly into higher sales volumes for manufacturers of such devices. Patients suffering from chronic respiratory diseases often require devices like nebulizers or oxygen concentrators. The growing patient population necessitates an expansion of product lines catering to these needs.
The rise in chronic diseases has prompted a shift in focus from reactive to preventive healthcare. There is a growing demand for products that facilitate early detection and management of chronic diseases, such as risk assessment tools and wellness monitoring devices. Nursing professionals require these tools to educate patients about lifestyle changes and disease management. With a focus on prevention, nursing products that assist in patient education, such as informational pamphlets, mobile health applications, and educational devices, are gaining traction. These resources empower patients to take an active role in managing their health. Chronic disease management is increasingly reliant on technological advancements. The rise of chronic diseases has accelerated the adoption of telehealth services, allowing healthcare providers to monitor patients remotely. Nursing products such as remote monitoring devices and telehealth software are essential in facilitating this shift, leading to increased market growth. Electronic health records (EHR) and data analytics platforms are becoming crucial for managing patient information, treatment plans, and follow-up schedules. These systems enhance care coordination for patients with chronic conditions, thus boosting the demand for related nursing products.
There is a significant correlation between the aging population and the prevalence of chronic diseases. Aging patients often require more complex care due to multiple chronic conditions. This complexity necessitates more nursing products to manage comprehensive care effectively, resulting in higher demand across various product categories. As more elderly individuals transition into long-term care facilities, these institutions must be equipped with the necessary nursing products to address chronic diseases, from mobility aids to specialized monitoring equipment. Healthcare organizations are implementing quality improvement programs to enhance chronic disease management. This focus leads to greater investments in nursing products that meet quality standards and compliance requirements. Many healthcare systems are creating incentives for facilities that effectively manage chronic diseases through nursing products. This drives the procurement of tools that can demonstrate measurable outcomes in patient care. Manufacturers are diversifying their product offerings to address specific chronic conditions. This includes the development of specialized kits, tools, and accessories tailored for diabetes care, cardiovascular monitoring, and more. Companies are increasingly forming partnerships with healthcare providers and technology firms to develop integrated solutions that address chronic disease management, thereby expanding their market reach.
Heightened Focus on Infection Control and Safety
The heightened focus on infection control and safety has emerged as a pivotal driver of growth in the global nursing products market, particularly in the wake of the COVID-19 pandemic. This increased awareness around hygiene and safety protocols has reshaped healthcare practices and transformed the demand landscape for nursing products. One of the most immediate impacts of the heightened focus on infection control is the surge in demand for personal protective equipment (PPE). Governments and healthcare organizations are enforcing stricter regulations regarding the use of PPE in healthcare settings. This has resulted in hospitals and clinics significantly increasing their procurement of items such as masks, gloves, gowns, and face shields, thereby driving growth in the nursing products market. The general public is now more aware of infection risks, leading to increased demand for PPE in both healthcare facilities and home care settings. Nurses require PPE not only for their safety but also to protect patients, thus expanding the market.
need for effective infection control has led to a rise in the demand for antiseptics, hand sanitizers, and surface disinfectants. Nursing facilities are now prioritizing the procurement of these products to ensure a sterile environment, impacting market growth. Advances in technology have spurred the development of innovative disinfection products, such as UV sterilizers and antimicrobial surfaces, which are becoming essential in healthcare settings. This innovation creates new opportunities for manufacturers in the nursing products market. There is a growing need for training materials and educational products that help nursing staff understand the latest infection control practices. This includes training kits, simulation tools, and instructional materials that promote proper PPE usage and hygiene practices. The development of standardized infection control protocols necessitates the use of specific nursing products that align with these guidelines. This drives the procurement of products designed for compliance with best practices. Healthcare facilities are increasingly investing in technologies that facilitate infection prevention and control, Advanced monitoring systems that track infection rates and hygiene compliance are gaining traction. These systems require complementary nursing products, such as wearable devices or integrated software solutions, which contribute to market growth. The pandemic accelerated the adoption of telehealth services as a means to reduce infection transmission. The demand for remote monitoring tools that support nursing care in a virtual environment has surged, further propelling the nursing products market.
Even beyond the pandemic, healthcare settings will likely maintain higher levels of PPE utilization, creating a sustained demand for these products in the nursing sector. The heightened awareness of infection risks has cultivated a cultural shift within healthcare organizations toward prioritizing safety. This shift influences purchasing decisions, leading to increased investment in nursing products that promote infection control. International health organizations and governments are providing funding for infection prevention programs, which often include the procurement of nursing products designed to enhance safety. This influx of funding supports market growth. Non-governmental organizations are increasingly involved in promoting infection control measures in healthcare settings, thereby driving demand for nursing products that align with these initiatives.
Key Market Challenges
Regulatory Compliance and Standards
Navigating the complex landscape of regulatory compliance poses a significant challenge for manufacturers and suppliers in the nursing products market.
Nursing products must adhere to rigorous regulatory standards set by governmental bodies such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and other local health authorities. These regulations often involve lengthy approval processes, stringent quality control measures, and extensive documentation. As a result, companies may face delays in bringing new products to market or incur substantial costs to meet compliance standards, limiting their ability to innovate and compete. The regulatory landscape is continuously evolving, particularly in response to emerging health threats and technological advancements. Companies must stay abreast of changing regulations, which requires ongoing investment in compliance training and systems. The inability to adapt swiftly to these changes can result in product recalls, fines, or loss of market access, creating significant financial burdens.
High Competition and Market Saturation
The nursing products market is characterized by intense competition and increasing market saturation, with the rising demand for nursing products, many new entrants are entering the market, intensifying competition. These new players often adopt aggressive pricing strategies or innovative approaches to capture market share. Established companies may struggle to maintain their competitive edge and pricing power, which can erode profit margins. As the market becomes saturated with similar products, differentiating offerings becomes increasingly difficult. Companies may find it challenging to convey unique value propositions to healthcare providers and consumers. The lack of differentiation can lead to price wars, reduced profitability, and ultimately, stagnation in market growth.
Key Market Trends
Technological Advancements and Integration
The rapid pace of technological innovation is transforming the nursing products market, leading to enhanced efficiency, safety, and patient outcomes. The integration of Internet of Things (IoT) technology into nursing products is revolutionizing patient care. Smart medical devices that enable real-time monitoring, data collection, and remote access are becoming increasingly prevalent. For instance, wearable health monitors can track vital signs and alert nursing staff to changes in a patient’s condition, facilitating timely interventions. This trend enhances the demand for advanced nursing products that improve the quality of care while reducing hospital readmission rates.
The growth of telehealth services, accelerated by the COVID-19 pandemic, has changed how healthcare is delivered. Nursing products that support telehealth, such as remote monitoring tools and mobile health applications, are increasingly in demand. These solutions enable nurses to conduct virtual consultations, monitor patients remotely, and manage chronic diseases more effectively. As healthcare systems continue to embrace telehealth as a standard practice, the market for nursing products that facilitate these services is expected to expand significantly.
Focus on Personalized and Patient-Centric Care
The healthcare landscape is shifting towards a more personalized and patient-centric approach, which is driving innovation and growth in the nursing products market.
There is a growing emphasis on individualized care plans that cater to the specific needs of patients, particularly those with chronic diseases or complex health conditions. This trend is leading to the development of nursing products that can be customized or adapted to meet individual patient requirements, fostering better engagement and adherence to treatment plans. Products that enhance patient autonomy, such as self-management tools and educational resources, are becoming increasingly popular. Healthcare providers are recognizing the importance of the patient experience in improving overall outcomes. Nursing products that prioritize comfort, accessibility, and ease of use are gaining traction. For instance, ergonomic designs, user-friendly interfaces, and aesthetically pleasing products contribute to a positive patient experience, driving demand for innovative nursing solutions that meet these expectations.
Segmental Insights
Type Insights
Based on the category of Type, Breast Pump emerged as the fastest growing segment in the global market for Nursing Products in 2023. Organizations such as the World Health Organization (WHO) and the American Academy of Pediatrics (AAP) strongly recommend exclusive breastfeeding for the first six months of an infant's life, followed by continued breastfeeding alongside complementary foods. This advocacy creates a robust market for products that support breastfeeding, with breast pumps being essential tools for mothers who may be unable to breastfeed directly due to various reasons (e.g., work commitments, health issues). Governments and NGOs are investing in public health campaigns that promote breastfeeding and educate mothers about the benefits of using breast pumps. These initiatives contribute to a more informed consumer base, leading to increased adoption of breast pumps among nursing mothers.
Recent technological advancements have led to the development of electric and battery-operated breast pumps that offer superior suction and efficiency compared to traditional manual pumps. Innovations such as adjustable suction levels, dual pumping options, and smart technology (e.g., connectivity to mobile apps for tracking feeding schedules) enhance the overall experience for mothers, driving demand. Modern breast pumps are designed with portability in mind, allowing mothers to express milk discreetly and conveniently, whether at home or on the go. This focus on user-friendly designs, lightweight materials, and compact sizes caters to the lifestyles of busy mothers, making breast pumps an essential item in their nursing toolkit. The increasing participation of women in the labor force necessitates solutions that allow them to balance professional responsibilities with breastfeeding. Breast pumps enable mothers to maintain their milk supply while returning to work, making them indispensable for working mothers. Many employers are now providing support for breastfeeding, including designated lactation rooms and subsidized breast pumps, further propelling market demand. Breast pumps allow mothers to provide breast milk to their infants even when they are away, ensuring that infants receive the nutritional benefits of breast milk without necessitating direct breastfeeding. This flexibility is particularly appealing to working mothers, contributing to the segment's dominance. These factors collectively contribute to the growth of this segment.
Regional Insights
North America emerged as the dominant in the global Nursing Products market in 2023, holding the largest market share in terms of value. The region boasts a vast network of well-equipped hospitals, clinics, and nursing facilities that are increasingly focused on patient-centric care. This infrastructure supports the widespread adoption of nursing products, as healthcare providers prioritize quality care and safety. Continuous investment in healthcare services, driven by both public and private sectors, ensures that healthcare facilities are equipped with the latest nursing products. This includes advanced medical devices, personal protective equipment (PPE), and hygiene products, enhancing overall care standards.
There is a strong emphasis on maternal and child health education, leading to a well-informed consumer base. Parents and caregivers are increasingly aware of the benefits of breastfeeding and the importance of using appropriate nursing products, such as breast pumps and nursing pads. This awareness drives demand and encourages purchasing. Consumers in North America are inclined to prioritize high-quality products that ensure safety and efficacy. This trend prompts manufacturers to innovate and enhance their offerings to meet consumer expectations, further solidifying the region's dominance in the market. The presence of well-defined regulatory agencies, such as the U.S. Food and Drug Administration (FDA) and Health Canada, ensures that nursing products meet high safety and efficacy standards. These regulatory frameworks promote consumer confidence and encourage manufacturers to comply with stringent guidelines, ultimately enhancing product quality. Favorable reimbursement policies for nursing products, particularly breast pumps and postpartum supplies, facilitate access for consumers. Many insurance plans cover these products, reducing financial barriers and driving sales. This financial support incentivizes new mothers to invest in nursing products, further expanding the market.
Key Market Players
• Ameda, Inc
• Pigeon Corporation
• Koninklijke Philips N.V.
• daVinci Baby, inc.
• Bravado Designs USA
• Spectra Baby USA
• Earth Mama Organics
• Medela
• NuAngel, Inc.
• The Honest Company, Inc.
Report Scope:
In this report, the Global Nursing Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
• Nursing Products Market, By Type:
o Breast Pump
o Nursing Bra
o Nipple Cream
o Pumping Accessories
o Nursing Pillow
o Nursing Cover
o Nursing Pad
o Nursing Station
o Others
• Nursing Products Market, By Region:
o North America
§ United States
§ Canada
§ Mexico
o Europe
§ France
§ United Kingdom
§ Italy
§ Germany
§ Spain
o Asia-Pacific
§ China
§ India
§ Japan
§ Australia
§ South Korea
o South America
§ Brazil
§ Argentina
§ Colombia
o Middle East & Africa
§ South Africa
§ Saudi Arabia
§ UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Nursing Products Market.
Available Customizations:
Global Nursing Products market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).
ページTOPに戻る
Table of Contents
1.Product Overview
1.1.Market Definition
1.2.Scope of the Market
1.2.1.Markets Covered
1.2.2.Years Considered for Study
1.2.3.Key Market Segmentations
2.Research Methodology
2.1.Objective of the Study
2.2.Baseline Methodology
2.3.Key Industry Partners
2.4.Major Association and Secondary Sources
2.5.Forecasting Methodology
2.6.Data Triangulation Validations
2.7.Assumptions and Limitations
3.Executive Summary
3.1.Overview of the Market
3.2.Overview of Key Market Segmentations
3.3.Overview of Key Market Players
3.4.Overview of Key Regions/Countries
3.5.Overview of Market Drivers, Challenges, Trends
4.Voice of Customer
5.Global Alzheimer’s Therapeutics Market Outlook
5.1.Market Size Forecast
5.1.1.By Value
5.2.Market Share Forecast
5.2.1.By Product Type (Cholinesterase inhibitors {Donepezil, Galantamine, Rivastigmine}, NMDA Receptor Antagonist, Combination Drug, Pipeline Drugs)
5.2.2.By End User (Hospital Pharmacy, Retail Pharmacy, E-commerce)
5.2.3.By Region
5.2.4.By Company (2023)
5.3.Market Map
6.North America Alzheimer’s Therapeutics Market Outlook
6.1.Market Size Forecast
6.1.1.By Value
6.2.Market Share Forecast
6.2.1.By Product Type
6.2.2.By End User
6.2.3.By Country
6.3.North America: Country Analysis
6.3.1.United States Alzheimer’s Therapeutics Market Outlook
6.3.1.1.Market Size Forecast
6.3.1.1.1.By Value
6.3.1.2.Market Share Forecast
6.3.1.2.1.By Product Type
6.3.1.2.2.By End User
6.3.2.Canada Alzheimer’s Therapeutics Market Outlook
6.3.2.1.Market Size Forecast
6.3.2.1.1.By Value
6.3.2.2.Market Share Forecast
6.3.2.2.1.By Product Type
6.3.2.2.2.By End User
6.3.3.Mexico Alzheimer’s Therapeutics Market Outlook
6.3.3.1.Market Size Forecast
6.3.3.1.1.By Value
6.3.3.2.Market Share Forecast
6.3.3.2.1.By Product Type
6.3.3.2.2.By End User
7.Europe Alzheimer’s Therapeutics Market Outlook
7.1.Market Size Forecast
7.1.1.By Value
7.2.Market Share Forecast
7.2.1.By Product Type
7.2.2.By End User
7.2.3.By Country
7.3.Europe: Country Analysis
7.3.1.United Kingdom Alzheimer’s Therapeutics Market Outlook
7.3.1.1.Market Size Forecast
7.3.1.1.1.By Value
7.3.1.2.Market Share Forecast
7.3.1.2.1.By Product Type
7.3.1.2.2.By End User
7.3.2.Germany Alzheimer’s Therapeutics Market Outlook
7.3.2.1.Market Size Forecast
7.3.2.1.1.By Value
7.3.2.2.Market Share Forecast
7.3.2.2.1.By Product Type
7.3.2.2.2.By End User
7.3.3.France Alzheimer’s Therapeutics Market Outlook
7.3.3.1.Market Size Forecast
7.3.3.1.1.By Value
7.3.3.2.Market Share Forecasty
7.3.3.2.1.By Product Type
7.3.3.2.2.By End User
7.3.4.Italy Alzheimer’s Therapeutics Market Outlook
7.3.4.1.Market Size Forecast
7.3.4.1.1.By Value
7.3.4.2.Market Share Forecast
7.3.4.2.1.By Product Type
7.3.4.2.2.By End User
7.3.5.Spain Alzheimer’s Therapeutics Market Outlook
7.3.5.1.Market Size Forecast
7.3.5.1.1.By Value
7.3.5.2.Market Share Forecast
7.3.5.2.1.By Product Type
7.3.5.2.2.By End User
8.Asia-Pacific Alzheimer’s Therapeutics Market Outlook
8.1.Market Size Forecast
8.1.1.By Value
8.2.Market Share Forecast
8.2.1.By Product Type
8.2.2.By End User
8.2.3.By Country
8.3.Asia-Pacific: Country Analysis
8.3.1.China Alzheimer’s Therapeutics Market Outlook
8.3.1.1.Market Size Forecast
8.3.1.1.1.By Value
8.3.1.2.Market Share Forecast
8.3.1.2.1.By Product Type
8.3.1.2.2.By End User
8.3.2.India Alzheimer’s Therapeutics Market Outlook
8.3.2.1.Market Size Forecast
8.3.2.1.1.By Value
8.3.2.2.Market Share Forecast
8.3.2.2.1.By Product Type
8.3.2.2.2.By End User
8.3.3.Japan Alzheimer’s Therapeutics Market Outlook
8.3.3.1.Market Size Forecast
8.3.3.1.1.By Value
8.3.3.2.Market Share Forecast
8.3.3.2.1.By Product Type
8.3.3.2.2.By End User
8.3.4.South Korea Alzheimer’s Therapeutics Market Outlook
8.3.4.1.Market Size Forecast
8.3.4.1.1.By Value
8.3.4.2.Market Share Forecast
8.3.4.2.1.By Product Type
8.3.4.2.2.By End User
8.3.5.Australia Alzheimer’s Therapeutics Market Outlook
8.3.5.1.Market Size Forecast
8.3.5.1.1.By Value
8.3.5.2.Market Share Forecast
8.3.5.2.1.By Product Type
8.3.5.2.2.By End User
9.South America Alzheimer’s Therapeutics Market Outlook
9.1.Market Size Forecast
9.1.1.By Value
9.2.Market Share Forecast
9.2.1.By Product Type
9.2.2.By End User
9.2.3.By Country
9.3.South America: Country Analysis
9.3.1.Brazil Alzheimer’s Therapeutics Market Outlook
9.3.1.1.Market Size Forecast
9.3.1.1.1.By Value
9.3.1.2.Market Share Forecast
9.3.1.2.1.By Product Type
9.3.1.2.2.By End User
9.3.2.Argentina Alzheimer’s Therapeutics Market Outlook
9.3.2.1.Market Size Forecast
9.3.2.1.1.By Value
9.3.2.2.Market Share Forecast
9.3.2.2.1.By Product Type
9.3.2.2.2.By End User
9.3.3.Colombia Alzheimer’s Therapeutics Market Outlook
9.3.3.1.Market Size Forecast
9.3.3.1.1.By Value
9.3.3.2.Market Share Forecast
9.3.3.2.1.By Product Type
9.3.3.2.2.By End User
10.Middle East and Africa Alzheimer’s Therapeutics Market Outlook
10.1.Market Size Forecast
10.1.1.By Value
10.2.Market Share Forecast
10.2.1.By Product Type
10.2.2.By End User
10.2.3.By Country
10.3.MEA: Country Analysis
10.3.1.South Africa Alzheimer’s Therapeutics Market Outlook
10.3.1.1.Market Size Forecast
10.3.1.1.1.By Value
10.3.1.2.Market Share Forecast
10.3.1.2.1.By Product Type
10.3.1.2.2.By End User
10.3.2.Saudi Arabia Alzheimer’s Therapeutics Market Outlook
10.3.2.1.Market Size Forecast
10.3.2.1.1.By Value
10.3.2.2.Market Share Forecast
10.3.2.2.1.By Product Type
10.3.2.2.2.By End User
10.3.3.UAE Alzheimer’s Therapeutics Market Outlook
10.3.3.1.Market Size Forecast
10.3.3.1.1.By Value
10.3.3.2.Market Share Forecast
10.3.3.2.1.By Product Type
10.3.3.2.2.By End User
11.Market Dynamics
11.1.Drivers
11.2.Challenges
12.Market Trends Developments
12.1.Recent Development
12.2.Mergers Acquisitions
12.3.Product Launches
13.Global Alzheimer’s Therapeutics Market: SWOT Analysis
14.Porter’s Five Forces Analysis
14.1.Competition in the Industry
14.2.Potential of New Entrants
14.3.Power of Suppliers
14.4.Power of Customers
14.5.Threat of Substitute Products
15.Competitive Landscape
15.1.Eisai Co., Ltd.
15.1.1.Business Overview
15.1.2.Company Snapshot
15.1.3.Products Services
15.1.4.Financials (As Reported)
15.1.5.Recent Developments
15.1.6.Key Personnel Details
15.1.7.SWOT Analysis
15.2.Novartis AG
15.3.AbbVie Inc. (Allergan Plc.)
15.4.Adamas Pharmaceuticals, Inc.
15.5.H. Lundbeck A/S
15.6.Biogen Inc.
15.7.AC Immune SA
15.8.F. Hoffmann La Roche Ltd.
15.9.Daiichi Sankyo Company, Limited
15.10.Johnson Johnson
16.Strategic Recommendations
17.About Us Disclaimer
